Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells

Journal of Asian Natural Products Research

Volumn 13, Issue 3, 2011, Pages 242-250

  Yu, Hai Bo ^a   Zhang, Hui Feng ^a   Li, De Yu ^a   Zhang, Xiao ^a   Xue, Huan Zhou ^a   Zhao, Si Hai ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

invasion; matrine; MMP 9; NF kappa B

Indexed keywords

GELATIN; GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRINE;

ARTICLE; CANCER INVASION; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; DRUGS, CHINESE HERBAL; HUMANS; MATRIX METALLOPROTEINASE 9; MOLECULAR STRUCTURE; NF-KAPPA B; QUINOLIZINES; SOPHORA;

SOPHORA FLAVESCENS;

EID: 79952780900     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2010.551641     Document Type: Article

References (25)

1. D. Parkin, F. Bray, J. Ferlay, and P. Pisani, CA. Cancer. J. Clin. 55, 74 (2005).
2. I. Vlodavsky and Y. Friedmann, J. Clin. Invest. 108, 341 (2001).
3. M. Egeblad and Z. Werb, Nat. Rev. Cancer. 2, 161 (2002).
4. M. Joseph, S. Dangi-Garimella, M. Shields, M. Diamond, L. Sun, J. Koblinski, and H. Munshi, J. Cell. Biochem. 108, 726 (2009).
5. J. Oh, J. Kim, H. Ahn, J. Yoon, S. Yoo, D. Choi, I. Lee, H. Ryu, and C. Min, Gynecol. Oncol. 114, 509 (2009).
6. D. Nart, B. Yaman, F. Yilmaz, M. Zeytunlu, Z. Karasu, and M. Kiliç, Liver. Transpl. 16, 621 (2010).
7. M.H. Sun, X.C. Han, M.K. Jia, W.D. Jiang, M. Wang, H. Zhang, G. Han, and Y. Jiang, World J. Gastroenterol. 11, 5931 (2005).
8. R. Sen and D. Baltimore, Cell 47, 921 (1986).
9. A. Bharti and B. Aggarwal, Biochem. Pharmacol. 64, 883 (2002).
10. M. Fujita, K. Goto, K. Yoshida, H. Okamura, H. Morimoto, S. Kito, J. Fukuda, and T. Haneji, Oral. Oncol. 40, 199 (2004).
11. M.F. Hou, S.B. Lin, S.S. Yuan, S.M. Tsai, S.H. Wu, F. Ou-Yang, J.S. Hsieh, K.B. Tsai, T.J. Huang, and L.Y. Tsai, Clin. Chim. Acta 334, 137 (2003).
12. M. Shehata, M. Shehata, F. Shehata, and A. Pater, Cell. Biol. Int. 28, 895 (2004).
13. Y.Y. Yu, Q. Li, and Z.G. Zhu, Eur. J. Surg. Oncol. 31, 386 (2005).
14. A. Granado-Serrano, M. Martín, L. Bravo, L. Goya, and S. Ramos, Nutr. Cancer. 62, 390 (2010).
15. A. Keutgens, I. Robert, P. Viatour, and A. Chariot, Biochem. Pharmacol. 72, 1069 (2006).
16. Z. Suo, Y. Liu, M. Ferreri, T. Zhang, Z. Liu, X. Mu, and B. Han, J. Ethnopharmacol. 125, 404 (2009).
17. J.Y. Liu, J.H. Hu, Q.G. Zhu, F.Q. Li, J. Wang, and H.J. Sun, Int. Immunopharmacol. 7, 816 (2007).
18. H. Jiang, C. Hou, S. Zhang, H. Xie, W. Zhou, Q. Jin, X. Cheng, R. Qian, and X. Zhang, Eur. J. Pharmacol. 559, 98 (2007).
19. Y. Li, B. Wang, C. Zhou, and Y. Bi, Basic Clin. Pharmacol. Toxicol. 101, 1 (2007).
20. S. Zhang, J. Qi, L. Sun, B. Cheng, S. Pan, M. Zhou, and X. Sun, Mol. Biol. Rep. 36, 791 (2009).
21. W. Stetler-Stevenson, J. Clin. Invest. 103, 1237 (1999).
22. A. Hlobilkova, J. Ehrmann, P. Knizetova, V. Krejci, O. Kalita, and Z. Kolar, Neoplasma. 56, 284 (2009).
23. J. Park, Y. Jeong, K. Park, H. Cho, I. Chung, K. Min, M. Kim, K. Lee, J. Yeo, K. Park, and Y. Chang, Mol. Cells. 29, 209 (2010).
24. M. Bond, R. Fabunmi, A. Baker, and A. Newby, FEBS Lett. 435, 29 (1998).
25. J.J. Li, C. Westergaard, P. Ghosh, and N. Colburn, Cancer. Res. 57, 3569 (1997).